Loading clinical trials...
Loading clinical trials...
Prospective, Randomized, Open-Label, Controlled Study to Evaluate the Safety and Efficacy of Intensive Glycemic Control on Outcomes Following Liver Transplantation
Conditions
Interventions
Insulin
Locations
1
United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Start Date
April 1, 2009
Primary Completion Date
December 1, 2015
Completion Date
May 1, 2016
Last Updated
December 23, 2016
NCT00106925
NCT07046910
NCT05732779
NCT07006532
NCT06532890
NCT06990711
Lead Sponsor
Northwestern University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions